CompletedPhase 4

Intraoperative Floppy Iris Syndrome

United States28 participantsStarted 2007-06

Plain-language summary

An assessment of the surgical performance of DisCoVisc compared to Healon5 during cataract surgery with intraocular lens implantation where miotic/small pupils or intraoperative Floppy Iris Syndrome exists.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosed with floppy iris syndrome * operable bilateral cataracts Exclusion Criteria: * Intraocular Pressure (IOP) \> 21mmHg * ocular inflammatory disease * systemic or ocular diseases affecting Endothelial Cell Count

What they're measuring

Corneal Endothelial Cell Loss

Timeframe: 1 month

Trial details

NCT IDNCT00711347

SponsorAlcon Research

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2008-04

Results submitted2009-09-09

View on ClinicalTrials.gov More Cataract trials